Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
PHARMA HOLD from Binche, company number BE0473861727, closed financial year 2025 with a result of € -223 after tax. For that financial year PHARMA HOLD recorded a gross margin of € 10,346 and equity of € 142,224. Compared with financial year 2024, the result moved from € -6,895 to € -223. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 142,224
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -223
▲ 97 % less loss than in 2024
Profit after tax over the fiscal year.
€ 20,013
▼ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 4,804.
People and assets in 2025
€ 11,550
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 62
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 10,174 | € 9,912 | € 10,415 | € 10,346 | ▼ 1% |
| Profit after taxes | € -7,120 | € -7,433 | € -6,895 | € -223 | ▲ € 6,672 |
| Equity | € 156,773 | € 149,341 | € 142,446 | € 142,224 | |
| Total debts | € 179,102 | € 173,801 | € 166,857 | € 162,359 | ▼ 3% |
| Cash | € 34,179 | € 30,978 | € 31,912 | € 20,013 | ▼ 37% |
| Land & buildings | € 327,914 | € 314,741 | € 301,569 | € 288,396 | ▼ 4% |
| Retained profit | € 19,353 | € 11,921 | € 5,026 | € 4,804 | ▼ 4% |
| Bank debt | € 8,333 | € 3,333 | € 0 | € 0 | |
| Balance sheet total | € 382,990 | € 368,515 | € 352,865 | € 338,470 | ▼ 4% |
Key figures of PHARMA HOLD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA HOLD?
What happened at PHARMA HOLD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- RAPHAEL GRECO stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 223. Source: NBB ↗
- ANNIE DECLEVE became a director. NBB
- RAPHAEL GRECO became a director. NBB
- New establishment in La Louvière. KBO
- Start of the company according to the CBE. KBO
In short
From € 7,120 loss in 2022 to € 223 loss in 2025.
Paid € 62 in corporate taxes since 2022.
Management
Behind PHARMA HOLD are ANNIE DECLEVE and Anne-Catherine BAUS.
Directors
According to the 2025 annual accounts
ANNIE DECLEVE
Managing director
since 2021
Anne-Catherine BAUS
Director
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Rue Georges Dehavay(BIN) 47 box 4
7130 Binche
Rue Jules Monoyer(H-A) 101
7110 La Louvière
Active since 13 April 2001
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.861.727
- VAT number
- BE 0473.861.727
- Registered office
- Rue Georges Dehavay(BIN) 47 bus 4, 7130 Binche
- Names & denominations
- PHARMA HOLD
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 2001
- Peppol
- Not registered